PeptideDB

Nikethamide                                            DEA controlled substance 59-26-7

Nikethamide DEA controlled substance 59-26-7

CAS No.: 59-26-7

Nikethamide is one of the respiratory center activators and may be utilized in the research/study of respiratory failure
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Nikethamide is one of the respiratory center activators and may be utilized in the research/study of respiratory failure.

Physicochemical Properties


Molecular Formula C10H14N2O
Molecular Weight 178.23
Exact Mass 178.11
CAS # 59-26-7
PubChem CID 5497
Appearance Colorless to light yellow liquid(Density:1.06 g/cm3 )
Density 1.0±0.1 g/cm3
Boiling Point 298.0±0.0 °C at 760 mmHg
Melting Point 23 °C(lit.)
Flash Point 141.1±20.4 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.520
LogP 0.33
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 3
Heavy Atom Count 13
Complexity 166
Defined Atom Stereocenter Count 0
SMILES

O=C(C1=C([H])N=C([H])C([H])=C1[H])N(C([H])([H])C([H])([H])[H])C([H])([H])C([H])([H])[H]

Synonyms

beta-PyrimidumAnacardone Astrocar Anacordone
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Simultaneous determination of nikethamide and lidocaine in human blood and cerebrospinal fluid by high performance liquid chromatography. J Pharm Biomed Anal. 2007 Apr 11;43(5):1757-62.

Additional Infomation Nicethamid appears as clear light yellow viscous liquid or crystalline solid. Slightly bitter taste followed by a faint sensation of the warmth. (NTP, 1992)
Nikethamide is a pyridinecarboxamide. It is functionally related to a nicotinamide.
Nikethamide has been reported in Corydalis with data available.
A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)

Solubility Data


Solubility (In Vitro) H2O : ≥ 50 mg/mL (~280.54 mM)
DMSO : ≥ 1 mg/mL (~5.61 mM)
Solubility (In Vivo) Solubility in Formulation 1: 100 mg/mL (561.07 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.6107 mL 28.0536 mL 56.1073 mL
5 mM 1.1221 mL 5.6107 mL 11.2215 mL
10 mM 0.5611 mL 2.8054 mL 5.6107 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.